NO20025134L - Anvendelse av azalid-antibiotiske sammensetninger for behandling eller forebygging av bakteriell eller protozo infeksjon hos pattedyr - Google Patents

Anvendelse av azalid-antibiotiske sammensetninger for behandling eller forebygging av bakteriell eller protozo infeksjon hos pattedyr

Info

Publication number
NO20025134L
NO20025134L NO20025134A NO20025134A NO20025134L NO 20025134 L NO20025134 L NO 20025134L NO 20025134 A NO20025134 A NO 20025134A NO 20025134 A NO20025134 A NO 20025134A NO 20025134 L NO20025134 L NO 20025134L
Authority
NO
Norway
Prior art keywords
mammals
bacterial
prevention
treatment
protozoal infection
Prior art date
Application number
NO20025134A
Other languages
English (en)
Norwegian (no)
Other versions
NO20025134D0 (no
Inventor
Wayne Alan Boettner
Peter Connor Canning
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO20025134D0 publication Critical patent/NO20025134D0/no
Publication of NO20025134L publication Critical patent/NO20025134L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
NO20025134A 2000-04-27 2002-10-25 Anvendelse av azalid-antibiotiske sammensetninger for behandling eller forebygging av bakteriell eller protozo infeksjon hos pattedyr NO20025134L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19996100P 2000-04-27 2000-04-27
PCT/IB2001/000519 WO2001081358A1 (fr) 2000-04-27 2001-03-26 Utilisation de compositions antibiotiques de type azalide pour traiter ou prevenir une infection d'origine bacterienne ou protozoaire chez les mammiferes

Publications (2)

Publication Number Publication Date
NO20025134D0 NO20025134D0 (no) 2002-10-25
NO20025134L true NO20025134L (no) 2002-12-19

Family

ID=22739732

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20025134A NO20025134L (no) 2000-04-27 2002-10-25 Anvendelse av azalid-antibiotiske sammensetninger for behandling eller forebygging av bakteriell eller protozo infeksjon hos pattedyr

Country Status (30)

Country Link
US (2) US20020019353A1 (fr)
EP (1) EP1276747A1 (fr)
JP (1) JP2004516233A (fr)
KR (1) KR20030031479A (fr)
CN (1) CN1227258C (fr)
AP (1) AP2002002652A0 (fr)
AR (1) AR028041A1 (fr)
AU (1) AU4269301A (fr)
BG (1) BG107168A (fr)
BR (1) BR0110382A (fr)
CA (1) CA2407448A1 (fr)
CZ (1) CZ20023409A3 (fr)
EA (1) EA200200995A1 (fr)
GT (1) GT200100063A (fr)
HU (1) HUP0300585A3 (fr)
IL (1) IL152421A0 (fr)
IS (1) IS6559A (fr)
MA (1) MA26896A1 (fr)
MX (1) MXPA02010586A (fr)
NO (1) NO20025134L (fr)
OA (1) OA12257A (fr)
PA (1) PA8515601A1 (fr)
PE (1) PE20011188A1 (fr)
PL (1) PL359861A1 (fr)
SK (1) SK14882002A3 (fr)
TN (1) TNSN01063A1 (fr)
UY (1) UY26678A1 (fr)
WO (1) WO2001081358A1 (fr)
YU (1) YU78702A (fr)
ZA (1) ZA200208603B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003040782A (ja) * 2001-05-31 2003-02-13 Pfizer Prod Inc アザリド抗生物質組成物
WO2003011266A2 (fr) * 2001-08-01 2003-02-13 Pfizer Products Inc. Compositions antibiotiques azalides
US20060073172A1 (en) * 2004-10-01 2006-04-06 Schneider L W Stabilized ophthalmic solution for the treatment of glaucoma and lowering intraocular pressure
DE102006010642A1 (de) * 2006-03-08 2007-09-27 Bayer Healthcare Aktiengesellschaft Arzneimittelformulierungen, enthaltend Fluorchinolone
WO2009006466A1 (fr) * 2007-07-02 2009-01-08 Novus International Inc. Régime alimentaire permettant la prévention d'affections entéropathiques porcines
US8314071B2 (en) 2007-12-21 2012-11-20 Massachusetts Institute Of Technology Bioactive molecules from co-cultivation of microbes
MX348831B (es) * 2011-03-04 2017-06-30 Gruenenthal Gmbh Administración parenteral de tapentadol.
US10568923B2 (en) * 2012-06-27 2020-02-25 Kemin Industries, Inc. Plant parts and extracts having anticoccidial activity
WO2014004761A2 (fr) * 2012-06-27 2014-01-03 Kemin Industries, Inc. Parties et extraits végétaux à activité anticoccidienne
ES3027568T3 (en) 2016-12-15 2025-06-16 Nestle Sa Compositions and methods that modulate bacteria in a companion animal
CN106905396A (zh) * 2017-02-21 2017-06-30 西南大学 富马酸替米考星复盐的制备方法
CN106749458A (zh) * 2017-02-21 2017-05-31 西南大学 苹果酸替米考星复盐的制备方法
CN106905395A (zh) * 2017-02-21 2017-06-30 西南大学 丁二酸替米考星复盐的制备方法
CA3054023A1 (fr) * 2017-02-22 2018-08-30 Immune System Regulation Holding Ab Nouveaux macrolides de stimulation immunitaire
SMT202600094T1 (it) * 2018-11-19 2026-03-09 Harvard College Macrolidi a 13 membri sostituiti con c10-alchilene e loro impiego
CN109535211B (zh) * 2018-12-19 2020-05-08 江苏威凌生化科技有限公司 一种合成纯化泰拉霉素杂质c的方法
EP4118092B1 (fr) 2020-03-12 2025-07-16 Zoetis Services LLC Azalides immunomodulateurs o-het-aryle
MX2024002892A (es) * 2021-09-07 2024-04-05 Zoetis Services Llc Azalidos inmunomoduladores.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5698155A (en) * 1991-05-31 1997-12-16 Gs Technologies, Inc. Method for the manufacture of pharmaceutical cellulose capsules
HN1998000086A (es) * 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
US6239112B1 (en) * 1998-07-09 2001-05-29 Merial, Inc. Water miscible macrolide solutions
US6100240A (en) * 1998-10-09 2000-08-08 Pfizer Inc Macrolide derivatives
UA70972C2 (uk) * 1998-11-20 2004-11-15 Пфайзер Продактс Інк. 13-членні азаліди і їх застосування як антибіотиків

Also Published As

Publication number Publication date
JP2004516233A (ja) 2004-06-03
NO20025134D0 (no) 2002-10-25
ZA200208603B (en) 2003-10-24
PL359861A1 (en) 2004-09-06
CN1227258C (zh) 2005-11-16
MA26896A1 (fr) 2004-12-20
YU78702A (sh) 2005-11-28
WO2001081358A1 (fr) 2001-11-01
HUP0300585A2 (hu) 2003-06-28
AR028041A1 (es) 2003-04-23
TNSN01063A1 (fr) 2005-11-10
BR0110382A (pt) 2003-06-24
AP2002002652A0 (en) 2002-12-31
CZ20023409A3 (cs) 2004-01-14
SK14882002A3 (en) 2004-11-03
OA12257A (en) 2003-11-06
PE20011188A1 (es) 2001-11-24
BG107168A (bg) 2003-07-31
PA8515601A1 (es) 2002-07-30
KR20030031479A (ko) 2003-04-21
CN1429232A (zh) 2003-07-09
GT200100063A (es) 2002-02-18
IL152421A0 (en) 2003-05-29
US20020019353A1 (en) 2002-02-14
HUP0300585A3 (en) 2003-09-29
EA200200995A1 (ru) 2003-04-24
US20040235759A1 (en) 2004-11-25
EP1276747A1 (fr) 2003-01-22
CA2407448A1 (fr) 2001-11-01
IS6559A (is) 2002-09-20
AU4269301A (en) 2001-11-07
UY26678A1 (es) 2001-12-28
MXPA02010586A (es) 2003-03-10

Similar Documents

Publication Publication Date Title
NO20025134D0 (no) Anvendelse av azalid-antibiotiske sammensetninger for behandling eller forebygging av bakteriell eller protozo infeksjonhos pattedyr
IT1306716B1 (it) Associazione di batteri lattici e suo uso per la prevenzione e/o iltrattamento terapeutico di infezioni e di stati infiammatori.
NO20015464L (no) Attenuerte mikroorganismer for behandling av infeksjon
HK1049656A1 (zh) Fab i抑制剂
GB0125222D0 (en) Composition for the treatment of microbial infections
DE60045394D1 (de) Zusammensetzungen gegen infektionen zur behandlung erkrankten gewebes wie z.b. fieberbläschen
ZA200507070B (en) Methods and compositions for the treatment and prevention of staphylococcus and other bacterial infections
EP1594444A3 (fr) Methodes et compositions destinees au traitement et a la prevention d'infections a staphylocoque ou autres infections bacteriennes
DE60041753D1 (de) Arzneimittel zur behandlung von c. pneumoniae infektionen
EP1171428A4 (fr) Inhibiteurs de fab i
AU2000255628A1 (en) Formulation comprising thymol useful in the treatment of drug resistant bacterial infections
NO20042199L (no) Lav peroksydkonsentrasjon for behandling eller forebygging av vaginale infeksjoner
NO20022816L (no) Behandling av virale infeksjoner ved anvendelse av Levovirin
NO20022949D0 (no) Attenuerte mikroorganismer for behandling av infeksjon
PT1200605E (pt) Gene de streptomyces avermitilis controlador da proporcao de avermectinas b2:b1
WO2002057281A3 (fr) Aminoglycosides utilises comme antibiotiques
AU2002241162A1 (en) Intimins in the prevention or treatment of infections:ii
EE200200671A (et) Hügromütsiin A derivaadid bakteriaalsete ja algloomadest põhjustatud infektsioonide ravimiseks
FI970933L (fi) Entraalinen rokote vaginaalisia infektioita vastaan
AU4706799A (en) Treatment of (staphylococcus) infections
AU2002246544A1 (en) Antimicrobial quinolone derivatives and use of the same to treat bacterial infections
HK1037637A (en) Treatment of bacterial infections
EP1439186A3 (fr) Intermédiaires pour macrolides antibactérielles et procinétiques
AU2003204710A1 (en) Attenuated microorganisms for the treatment of infection
HK1067113A (en) Methods and compositions for treating or preventing bacterial infection

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application